| Dr Michael Stuart Nason, OD | |
|
1075 Oakleaf Plantation Pkwy Ste 300, Orange Park, FL 32065-3625 | |
| (904) 449-7720 | |
| (904) 385-2077 |
| Full Name | Dr Michael Stuart Nason |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 32 Years |
| Location | 1075 Oakleaf Plantation Pkwy Ste 300, Orange Park, Florida |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073515284 | NPI | - | NPPES |
| 620019200 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152WC0802X | Optometrist - Corneal And Contact Management | OPC002692 (Florida) | Secondary |
| 152W00000X | Optometrist | OPC2692 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dr. Ted Brink And Associates Pa | 6800936360 | 10 |
News Archive
Ampio Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat prevalent inflammatory diseases, such as osteoarthritis (Ampion) and diabetic macular edema (Optina) and sexual dysfunction (Zertane) announced FDA acceptance of its POPE questionnaire, a modification of the Premature Ejaculation Profile (PEP) questionnaire that was used in the two successful Zertane Phase 3 clinical trials completed in Europe.
The Endocrine Society today issued a Clinical Practice Guideline (CPG) for the diagnosis and treatment of two types of rare adrenal tumors - pheochromocytomas and paragangliomas - that can raise the risk of cardiovascular disease and even death if left untreated.
Researchers from CNRS, Université Toulouse III - Paul Sabatier and IRD have elucidated new molecular mechanisms involved in resistance to visceral leishmaniasis, a serious parasitic infection.
In the first study to compare mental health-related emergency department (ED) visits between children with and without autism spectrum disorders (ASD), researchers found that ED visits are nine times more likely to be for psychiatric reasons if a child has an ASD diagnosis.
› Verified 4 days ago
| Provider Name | Healthy Eye |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1952555427 PECOS PAC ID: 1759446099 Enrollment ID: O20090219000516 |
News Archive
Ampio Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat prevalent inflammatory diseases, such as osteoarthritis (Ampion) and diabetic macular edema (Optina) and sexual dysfunction (Zertane) announced FDA acceptance of its POPE questionnaire, a modification of the Premature Ejaculation Profile (PEP) questionnaire that was used in the two successful Zertane Phase 3 clinical trials completed in Europe.
The Endocrine Society today issued a Clinical Practice Guideline (CPG) for the diagnosis and treatment of two types of rare adrenal tumors - pheochromocytomas and paragangliomas - that can raise the risk of cardiovascular disease and even death if left untreated.
Researchers from CNRS, Université Toulouse III - Paul Sabatier and IRD have elucidated new molecular mechanisms involved in resistance to visceral leishmaniasis, a serious parasitic infection.
In the first study to compare mental health-related emergency department (ED) visits between children with and without autism spectrum disorders (ASD), researchers found that ED visits are nine times more likely to be for psychiatric reasons if a child has an ASD diagnosis.
› Verified 4 days ago
| Provider Name | Dr. Ted Brink And Associates Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1427138650 PECOS PAC ID: 6800936360 Enrollment ID: O20091215000370 |
News Archive
Ampio Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat prevalent inflammatory diseases, such as osteoarthritis (Ampion) and diabetic macular edema (Optina) and sexual dysfunction (Zertane) announced FDA acceptance of its POPE questionnaire, a modification of the Premature Ejaculation Profile (PEP) questionnaire that was used in the two successful Zertane Phase 3 clinical trials completed in Europe.
The Endocrine Society today issued a Clinical Practice Guideline (CPG) for the diagnosis and treatment of two types of rare adrenal tumors - pheochromocytomas and paragangliomas - that can raise the risk of cardiovascular disease and even death if left untreated.
Researchers from CNRS, Université Toulouse III - Paul Sabatier and IRD have elucidated new molecular mechanisms involved in resistance to visceral leishmaniasis, a serious parasitic infection.
In the first study to compare mental health-related emergency department (ED) visits between children with and without autism spectrum disorders (ASD), researchers found that ED visits are nine times more likely to be for psychiatric reasons if a child has an ASD diagnosis.
› Verified 4 days ago
| Provider Name | Michael S Nason Od Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1083887400 PECOS PAC ID: 8224226527 Enrollment ID: O20110103000081 |
News Archive
Ampio Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat prevalent inflammatory diseases, such as osteoarthritis (Ampion) and diabetic macular edema (Optina) and sexual dysfunction (Zertane) announced FDA acceptance of its POPE questionnaire, a modification of the Premature Ejaculation Profile (PEP) questionnaire that was used in the two successful Zertane Phase 3 clinical trials completed in Europe.
The Endocrine Society today issued a Clinical Practice Guideline (CPG) for the diagnosis and treatment of two types of rare adrenal tumors - pheochromocytomas and paragangliomas - that can raise the risk of cardiovascular disease and even death if left untreated.
Researchers from CNRS, Université Toulouse III - Paul Sabatier and IRD have elucidated new molecular mechanisms involved in resistance to visceral leishmaniasis, a serious parasitic infection.
In the first study to compare mental health-related emergency department (ED) visits between children with and without autism spectrum disorders (ASD), researchers found that ED visits are nine times more likely to be for psychiatric reasons if a child has an ASD diagnosis.
› Verified 4 days ago
| Provider Name | Clarity Eye Center Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1902438286 PECOS PAC ID: 2163896101 Enrollment ID: O20230315000400 |
News Archive
Ampio Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat prevalent inflammatory diseases, such as osteoarthritis (Ampion) and diabetic macular edema (Optina) and sexual dysfunction (Zertane) announced FDA acceptance of its POPE questionnaire, a modification of the Premature Ejaculation Profile (PEP) questionnaire that was used in the two successful Zertane Phase 3 clinical trials completed in Europe.
The Endocrine Society today issued a Clinical Practice Guideline (CPG) for the diagnosis and treatment of two types of rare adrenal tumors - pheochromocytomas and paragangliomas - that can raise the risk of cardiovascular disease and even death if left untreated.
Researchers from CNRS, Université Toulouse III - Paul Sabatier and IRD have elucidated new molecular mechanisms involved in resistance to visceral leishmaniasis, a serious parasitic infection.
In the first study to compare mental health-related emergency department (ED) visits between children with and without autism spectrum disorders (ASD), researchers found that ED visits are nine times more likely to be for psychiatric reasons if a child has an ASD diagnosis.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Stuart Nason, OD 4415 Sidewinder Trl, Middleburg, FL 32068-3250 Ph: (561) 951-7285 | Dr Michael Stuart Nason, OD 1075 Oakleaf Plantation Pkwy Ste 300, Orange Park, FL 32065-3625 Ph: (904) 449-7720 |
News Archive
Ampio Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat prevalent inflammatory diseases, such as osteoarthritis (Ampion) and diabetic macular edema (Optina) and sexual dysfunction (Zertane) announced FDA acceptance of its POPE questionnaire, a modification of the Premature Ejaculation Profile (PEP) questionnaire that was used in the two successful Zertane Phase 3 clinical trials completed in Europe.
The Endocrine Society today issued a Clinical Practice Guideline (CPG) for the diagnosis and treatment of two types of rare adrenal tumors - pheochromocytomas and paragangliomas - that can raise the risk of cardiovascular disease and even death if left untreated.
Researchers from CNRS, Université Toulouse III - Paul Sabatier and IRD have elucidated new molecular mechanisms involved in resistance to visceral leishmaniasis, a serious parasitic infection.
In the first study to compare mental health-related emergency department (ED) visits between children with and without autism spectrum disorders (ASD), researchers found that ED visits are nine times more likely to be for psychiatric reasons if a child has an ASD diagnosis.
› Verified 4 days ago
Clay Eye Physicians And Surgeons Pa/fleming Island Optical Optometrist Medicare: Medicare Enrolled Practice Location: 2023 Professional Center Dr, Orange Park, FL 32073 Phone: 904-272-2020 Fax: 904-272-5762 | |
Dr. Keven Charles Reed, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 905 Park Ave Ste 100, Orange Park, FL 32073 Phone: 904-264-1206 Fax: 904-264-3685 | |
Jenna Rogers, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 28 Blanding Blvd, Orange Park, FL 32073 Phone: 904-264-5483 Fax: 904-213-0515 | |
Crystal Kaye Victor, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 28 Blanding Blvd, Orange Park, FL 32073 Phone: 904-264-5483 | |
Orange Park Eye Center Optometrist Medicare: Medicare Enrolled Practice Location: 905 Park Ave, 100, Orange Park, FL 32073 Phone: 904-264-1206 Fax: 904-264-3685 | |
Jennifer L. Balo, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 901 Blanding Blvd, Orange Park, FL 32065 Phone: 904-562-1160 |